Munar Pharma

Munar Pharma EBITDA Growth YoY

Delisted

The Year-over-Year EBITDA Growth of Munar Pharma (MUN.WA) as of Nov 20, 2026 is 74.68 %. In the previous year, Year-over-Year EBITDA Growth was -914.48 % — a change of -108.17% (higher).

EBITDA Growth YoY

74.68 %

YoY

-108.17%

Last updated:

Year-over-Year EBITDA Growth of Munar Pharma is 2024 74.68 % . Year-over-Year EBITDA Growth of Munar Pharma was 2023 -914.48 % . It decreases by -108.17% higher compared to the previous year.

The Munar Pharma EBITDA Growth YoY history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Growth YoY
Date
EBITDA Growth YoY
Jan 1, 2017
-960.18 PLN
Jan 1, 2018
-6,633.33 PLN
Jan 1, 2019
99.30 PLN
Jan 1, 2020
-1,592.16 PLN
Jan 1, 2021
28.36 PLN
Jan 1, 2022
117.69 PLN
Jan 1, 2023
-914.48 PLN
Jan 1, 2024
74.68 PLN
The Munar Pharma EBITDA Growth YoY history
YEAREBITDA Growth YoYYoY
74.68 %-108.17%
-914.48 %-877.06%
117.69 %+314.92%
28.36 %-101.78%
-1,592.16 %-1,703.40%
99.30 %-101.50%
-6,633.33 %+590.84%
-960.18 %+1,753.18%
-51.81 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Munar Pharma stock

Year-over-Year EBITDA Growth of Munar Pharma is 74.68 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year EBITDA Growth Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

EBITDA growth measures the percentage change in EBITDA compared to the prior year. It shows changes in operating cash earnings before capital structure effects.

To evaluate Year-over-Year EBITDA Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year EBITDA Growth.

Year-over-Year EBITDA Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year EBITDA Growth's Munar Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Munar Pharma

All Key Metrics — Munar Pharma